Kayvanfar John MD is categorized under Orthopedic Doctors and Physicians in Palmdale, CA and active since 1985.
Kayvanfar John MD was established in 1985, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John Kayvanfar at the company’s single location by writing to 40005 10th St West, Palmdale, California CA 93551 or by phoning (661) 947-0078. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Kayvanfar John MD |
Contact Person: | John Kayvanfar |
Address: | 40005 10th St West, Palmdale, California 93551 |
Phone Number: | (661) 947-0078 |
Website Address: | oosmg.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Kayvanfar John MD was started in 1985 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Kayvanfar for inquiries that concern Kayvanfar John MD by calling the company number (661) 947-0078, as your correspondence is most welcome. Additionally, the physical location of the single location of Kayvanfar John MD can be found at the coordinates 34.60969,-118.14786 as well as the street address 40005 10th St West in Palmdale, California 93551.
For its online presence, you may visit Kayvanfar John MD’s website at oosmg.com and engage with its social media outlets through on Twitter and on Facebook.